Live Breaking News & Updates on Sealy smith foundation

Stay informed with the latest breaking news from Sealy smith foundation on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Sealy smith foundation and stay connected to the pulse of your community

UTMB School of Medicine renamed in honor of billion-dollar donor

John Sealy and the Sealy & Smith Foundation have donated over $1 billion over the last 100 years to the University of Texas Medical Branch in Galveston, Texas.

Sealy-smith-foundation , Smith-foundation ,

COVID-19 Vaccines Likely Activate Strong, Lasting Immunity

COVID-19 Vaccines Likely Activate Strong, Lasting Immunity
govexec.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from govexec.com Daily Mail and Mail on Sunday newspapers.

South-africa , Ali-ellebedy , Jane-ohalloran , William-middleton , Sharlene-teefey , Jackson-turner , Rachel-presti , Among-carter-foundation , National-center , Helen-hay-whitney-foundation , Gilson-longenbaugh-foundation , National-institute-of-allergy

COVID-19 vaccines likely activate strong, lasting immunity

COVID-19 vaccines likely activate strong, lasting immunity
futurity.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from futurity.org Daily Mail and Mail on Sunday newspapers.

South-africa , Ali-ellebedy , Jane-ohalloran , William-middleton , Sharlene-teefey , Jackson-turner , Rachel-presti , Among-carter-foundation , National-center , Helen-hay-whitney-foundation , Gilson-longenbaugh-foundation , National-institute-of-allergy

COVID-19 Vaccines Promise Long Lasting Immunity: Washington University Research

COVID-19 Vaccines Promise Long Lasting Immunity: Washington University Research
insurancejournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insurancejournal.com Daily Mail and Mail on Sunday newspapers.

South-africa , Ali-ellebedy , Jane-ohalloran , William-middleton , Sharlene-teefey , Jackson-turner , Rachel-presti , Among-carter-foundation , National-center , Helen-hay-whitney-foundation , Gilson-longenbaugh-foundation , National-institute-of-allergy

Ribbon-cutting for renovated John Sealy Tower

The long-awaited renovation of the AB wing of John Sealy Hospital at the University of Texas Medical Branch Galveston Campus will mark its completion with a ribbon-cutting ceremony on June 3. Approximately 220,000 square feet were renovated across five different floors, which will house services for women, infants and children.

Jennie-sealy-hospital , Texas , United-states , John-sealy-hospital , University-of-texas , Texans , John-kelso , Ben-raimer , Joan-richardson , Division-of-neonatology , Sealy-smith-foundation , Department-of-pediatrics

Preclinical research reveals that new IgM antibodies administered intranasally to fight COVID-19 more potent than commonly used ones

A nasal therapy, built upon on the application of a new engineered IgM antibody therapy for COVID-19, was more effective than commonly used IgG antibodies at neutralizing the COVID-19 virus in animal models, according to research recently published by The University of Texas Health Science Center at Houston (UTHealth), The University of Texas Medical Branch at Galveston (UTMB Health), the University of Houston, and IGM Biosciences, Inc.

South-africa , University-of-houston , Texas , United-states , University-of-texas , Brazil , Kleberg , South-african , Brazilian , Stephenf-carroll , Vineetd-menachery , Xinli-liu

COVID vaccines might not work as well on new SARS-CoV-2 variants


Three new, fast-spreading variants of the virus that causes COVID-19 can evade antibodies that work against the original form that sparked the pandemic, new research shows.
With few exceptions, whether the antibodies were produced in response to vaccination or natural infection, or were purified antibodies intended for use as drugs, researchers found they needed more antibody to neutralize the new variants.
The findings, from laboratory-based experiments, suggest that COVID-19 drugs and vaccines developed thus far may become less effective as the new variants become dominant, as experts say they inevitably will. The researchers looked at variants from South Africa, the United Kingdom, and Brazil.

South-africa , United-kingdom , Brazil , Dolly-parton , Ritae-chen , Summerfield-robert-foundation , American-college-of-gastroenterology , Townsend-jeantet-charitable , Pfizer , Among-carter-foundation , Helen-hay-whitney-foundation , National-institutes-of-health